Design Therapeutics is set to present significant safety findings from its Phase 1 trial of DT-168, highlighting progress in their clinical development for treating Fuchs endothelial corneal dystrophy ...
IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from FDA Placing Clinical Hold on IND Application to Open U.S. Sites CARLSBAD, Calif., June 04, 2025 (GLOBE NEWSWIRE ...
DT Design to Focus on High-Impact Interactive Ad Units, Branded & Original Content, Infographics and more PORTLAND, OR – December 14, 2015 – Leading consumer technology lifestyle publisher Digital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results